Madrid-Wolff, Jorge
Toombs, Joseph
Rizzo, Riccardo
Bernal, Paulina Nuñez
Porcincula, Dominique
Walton, Rebecca
Wang, Bin
Kotz-Helmer, Frederik
Yang, Yi
Kaplan, David
Zhang, Yu Shrike
Zenobi-Wong, Marcy
McLeod, Robert R.
Rapp, Bastian
Schwartz, Johanna
Shusteff, Maxim
Talyor, Hayden
Levato, Riccardo
Moser, Christophe
Funding for this research was provided by:
National Institutes of Health (R01HL166522, NINDS R01 NS118188)
Lawrence Livermore National Laboratory (DE-AC52-07NA27344)
H2020 European Research Council (949806, 964497, 964497)
Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (196971)
EPFL Lausanne
Article History
Received: 30 April 2023
Accepted: 8 August 2023
First Online: 29 August 2023
Declarations
:
: FK is shareholder of Glassomer GmbH which is commerciallizing 3D printed glass. YSZ consults for Allevi by 3D Systems, and sits on the scientific advisory board and holds options of Xellar, neither of which however, participated in or biased the work. RM is a shareholder of Vitro3D which is commercializing volumetric additive manufacturing. RM has filed related provisional patents 63/483,147 and 63/181,645. RL is scientific advisor for Readily3D SA, which commercializes volumetric printers. CM is a shareholder of Readily3D SA. CM and JMW have filed provisional patent No. WO2022EP63245 20220517 regarding three-dimensional printing in complex media. All other authors declare no competing interests.